Derek DiRocco
Director/Board Member bij CONNECT BIOPHARMA HOLDINGS LIMITED
Vermogen: 38 054 $ op 29-02-2024
Profiel
Currently, Derek DiRocco occupies the position of Partner at RA Capital Management LP and Partner at RA Capital Management LP (Private Equity) (a subsidiary of RA Capital Management LP).
Dr. DiRocco is also on the board of 8 other companies.
He received an undergraduate degree from College of the Holy Cross (Massachusetts) and a doctorate from the University of Washington.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
24-04-2023 | 7 830 ( 0.04% ) | 38 054 $ | 29-02-2024 | |
09-02-2023 | 0 ( -.--% ) | - $ | 29-02-2024 | |
ITEOS THERAPEUTICS, INC.
-.--% | 13-06-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
89BIO INC
-.--% | 04-03-2024 | 0 ( -.--% ) | - $ | 29-02-2024 |
21-06-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Derek DiRocco
Bedrijven | Functie | Begin |
---|---|---|
89BIO, INC. | Director/Board Member | 01-04-2018 |
WEREWOLF THERAPEUTICS, INC. | Director/Board Member | 01-12-2020 |
CONNECT BIOPHARMA HOLDINGS LIMITED | Director/Board Member | 01-08-2020 |
ACRIVON THERAPEUTICS, INC. | Director/Board Member | 01-11-2021 |
MINERALYS THERAPEUTICS, INC. | Director/Board Member | 08-06-2022 |
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Analyst-Equity | - |
89Bio Ltd.
89Bio Ltd. Pharmaceuticals: MajorHealth Technology 89bio Ltd. develops therapies and drugs to treat patients with nonalcoholic steatohepatitis. The private company is based in Herzliya, Israel. | Director/Board Member | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Private Equity Investor | 01-12-2017 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Eerdere bekende functies van Derek DiRocco
Bedrijven | Functie | Einde |
---|---|---|
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░ ░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van Derek DiRocco
University of Washington | Doctorate Degree |
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 9 |
---|---|
89BIO, INC. | Health Technology |
WEREWOLF THERAPEUTICS, INC. | Health Technology |
ITEOS THERAPEUTICS, INC. | Health Technology |
ACRIVON THERAPEUTICS, INC. | Health Technology |
DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
ACHILLES THERAPEUTICS PLC | Health Technology |
MINERALYS THERAPEUTICS, INC. | Health Technology |
CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Finance |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Health Technology |
89Bio Ltd.
89Bio Ltd. Pharmaceuticals: MajorHealth Technology 89bio Ltd. develops therapies and drugs to treat patients with nonalcoholic steatohepatitis. The private company is based in Herzliya, Israel. | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Finance |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |